Approval · Notice of Compliance 21339 · 2018
LINESSA 21: Notice of Compliance 21339
Issued September 21, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21339
- Date
- September 21, 2018
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision of the design of the product labelling components
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LINESSA 21 | Not yet assigned | — |
| LINESSA 28 | Not yet assigned | — |
Medicinal ingredients
- DESOGESTREL 0.1 MG per TAB
- ETHINYL ESTRADIOL 0.025 MG per TAB
- DESOGESTREL 0.125 MG per TAB
- DESOGESTREL 0.15 MG per TAB